4:00 PM ET · Friday, November 13, 2026·Panel·50 min
Federal Rescheduling: Status + Strategy
S
Speakers TBD
About This Session
The DEA rescheduling rulemaking status as of November 2026: where the administrative record stands, what Schedule III means for §280E, pharmaceutical research access, federal contractor implications, and what operators should be doing now to position for federal normalization. Panel includes practitioners who submitted public comments on the proposed rule.
About the Speaker
Panel of federal cannabis law specialists including practitioners who engaged in the DEA rescheduling rulemaking process. Speakers confirmed 90 days before event.
Join Cannabis Law Day 2026
Register to access all 8 sessions, recordings, and your CLE certificate.